Rolf Lewensohns forskargrupp

This page in English

Utförligare information om Lewensohns forskargrupp finns på den engelska sidan.

Finansiering

Gruppmedlemmar

Rolf Lewensohn, MD, PhD, professor, gruppledare
Kristina Viktorsson, PhD, senior forskare
Petra Hååg, PhD, forskarassistent
Per Hydbring, PhD, forskarassistent
Lena Kanter, MD, PhD, patolog
Luigi De Petris, MD, PhD, onkolog, postdoc
Simon Ekman, MD, docent, onkolog
Karin Lindberg, MD, PhD
Metka Novak, PhD, postdoc
Katarzyna Zielinska-Chomej, MSc, docent, postdoc
Adam Sierakowiak, PhD, postdoc
Carl-Henrik Shah, MD, doktorand
Salomon Tendler, MD, doktorand
Georgios Tsakonas, MD, PhD-student
Liselotte Hälleberg, forskningssamordnare
Christina von Gertten, PhD, forskningssamordnare, EU-projektledare

Utvalda publikationer

Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.
Lindberg K, Nyman J, Riesenfeld Källskog V, Hoyer M, Lund J, Lax I, et al
Acta Oncol 2015 ;54(8):1096-104

25319389

Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer.
Zong D, Zielinska-Chomej K, Juntti T, Mörk B, Lewensohn R, Hååg P, et al
Cell Death Dis 2014 Mar;5():e1111

miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
Salim H, Arvanitis A, de Petris L, Kanter L, Hååg P, Zovko A, et al
Genes Chromosomes Cancer 2013 Oct;52(10):895-911

In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells.
Chauhan D, Ray A, Viktorsson K, Spira J, Paba-Prada C, Munshi N, et al
Clin. Cancer Res. 2013 Jun;19(11):3019-31

[pubmed:23303128]

miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence.
Salim H, Akbar N, Zong D, Vaculova A, Lewensohn R, Moshfegh A, et al
Br. J. Cancer 2012 Oct;107(8):1361-73

Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy.
Peulen H, Karlsson K, Lindberg K, Tullgren O, Baumann P, Lax I, et al
Radiother Oncol 2011 Nov;101(2):260-6

Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation.
Zong D, Hååg P, Yakymovych I, Lewensohn R, Viktorsson K
Cell Death Dis 2011 Jul;2():e181

Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
Ståhl S, Branca R, Efazat G, Ruzzene M, Zhivotovsky B, Lewensohn R, et al
J. Proteome Res. 2011 May;10(5):2566-78

Alla publikationer från Rolf Lewensohn

Lungcancer